Amir Toor

Amir Toor, M.D., is a Professor in the Department of Internal Medicine at the University of Texas Southwestern Medical Center, specializing in hematology, oncology, and stem cell transplantation. He holds faculty appointments in the Division of Hematology and Oncology and has previously served at institutions like Virginia Commonwealth University and Loyola University Medical Center. His research focuses on immune recovery post-transplant, cancer relapse prevention, and mathematical modeling in hematology.

Education: MD from King Edward Medical University (Pakistan), internal medicine residency at UConn Health, and hematology/oncology fellowship at the University of Minnesota.

Research Interests: Stem cell transplantation, cellular immunotherapy, graft-versus-host disease (GVHD), and the dynamics of immune recovery. He employs dynamical systems modeling to predict clinical outcomes and optimize therapeutic strategies.

Key Contributions: Over 90 peer-reviewed articles and 100+ abstracts, with a focus on KIR receptor interactions, vitamin C supplementation in transplant patients, and SARS-CoV-2 vaccination outcomes. His work bridges clinical practice and computational biology, emphasizing translational research.

Labs/Teams: Collaborates with the Division of Hematology and Oncology at UTSW, focusing on translational research in hematologic malignancies and transplant immunology.